speb/financial-data huggingface dataset:
FSY.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 210679467.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 347923.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -20097759.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1136000.00
FSY.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 311993.00
FSY.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 4009.00
FSY.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -28271.00
FSY.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 4444.00
FSY.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 81514.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 191040.00
FSY.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -515775.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 761947.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -185803023.00
FSY.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 154548.00
FSY.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 466541.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 210679467.00
FSY.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 0.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 25414434.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 25414434.00
FSY.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
FSY.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 25605474.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 25414434.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 25414434.00
FSY.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 548055.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 191040.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 20015111.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
FSY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -435.00
FSY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -435.00
FSY.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 5399323.00
FSY.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 504509.00
FSY.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 316782.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 49822289.00
FSY.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 210679467.00
FSY.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4480492.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 180356927.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2818035.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2818035.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 1260361.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 1557674.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1218832.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -507981.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 167497.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 167497.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 167497.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 12464.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -125159.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 54802.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1726813.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 180356927.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 25907082.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 3470276.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 358537.00
FSY.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 210679467.00
FSY.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
FSY.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — EBIT: -504509.00
FSY.TO income_statement (quarterly, 2025-09-30) — EBITDA: -504509.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 64356.00
FSY.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 2818035.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -507981.00
FSY.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 10938.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -19057487.00
FSY.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 432068.00
FSY.TO income_statement (quarterly, 2025-09-30) — Interest Income: 15159.00
FSY.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 15159.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 15159.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 25907082.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1218832.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -547624.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -547624.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 15159.00
FSY.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 15159.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -1233991.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 22213683.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 25907082.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 581660.00
FSY.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -515447.00
FSY.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -558562.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -507981.00
FSY.TO income_statement (quarterly, 2025-09-30) — Operating Income: -504509.00
FSY.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 210679467.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 335459.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -19057487.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1136000.00
FSY.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 276416.00
FSY.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -58274.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -15159.00
FSY.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -69212.00
FSY.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 72441.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 358537.00
FSY.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -547624.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 316782.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -186350647.00
FSY.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 155652.00
FSY.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 432068.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 210679467.00
FSY.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 25907082.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 25907082.00
FSY.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
FSY.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 26265619.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 25907082.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 25907082.00
FSY.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 504509.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 358537.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 22795343.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
FSY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 10938.00
FSY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 10938.00
FSY.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 3111739.00
FSY.TO income_statement (annual, 2025-12-31) — +Operating Expense: 2125590.00
FSY.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 506991.00
FSY.TO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
FSY.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
FSY.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 278955.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 278955.00
FSY.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 179827.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 179827.00
FSY.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 49822289.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 49822289.00
FSY.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 216298168.00
FSY.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.01
FSY.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3329334.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2818035.00
FSY.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -4340378.00
FSY.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 195100505.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 195100505.00
FSY.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 18706711.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18706711.00
FSY.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18706711.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 18706711.00
FSY.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 18163035.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 18163035.00
FSY.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 543676.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 543676.00
FSY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 22287672.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 17363578.00
FSY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4805537.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1161494.00
FSY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2260041.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -301549.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -54443.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -70247.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 0.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 0.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Payable: -54443.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -70247.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -54443.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -70247.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -70016.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 61716.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -31989.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 148424.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Tax Payable: 0.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 0.00
FSY.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -156448.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 139893.00
FSY.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 15222094.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 15900535.00
FSY.TO balance_sheet (annual, 2025-12-31) — Common Stock: 195100505.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 195100505.00
FSY.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 43519938.00
FSY.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 23930760.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 18925760.00
FSY.TO balance_sheet (annual, 2025-12-31) — Current Assets: 19163192.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 19163192.00
FSY.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 85527.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 85527.00
FSY.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 364482.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 364482.00
FSY.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 216298168.00
FSY.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
FSY.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — EBIT: -2125590.00
FSY.TO income_statement (quarterly, 2025-12-31) — EBIT: -506991.00
FSY.TO income_statement (annual, 2025-12-31) — EBITDA: -2125590.00
FSY.TO income_statement (quarterly, 2025-12-31) — EBITDA: -506991.00
FSY.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 155283.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -11859.00
FSY.TO cash_flow (annual, 2025-12-31) — End Cash Position: 18706711.00
FSY.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 18706711.00
FSY.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 22287672.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 17363578.00
FSY.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -6600419.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4641927.00
FSY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -2597.00
FSY.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -13078.00
FSY.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -18422492.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -18422492.00
FSY.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 1792800.00
FSY.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 434863.00
FSY.TO income_statement (annual, 2025-12-31) — Interest Income: 117048.00
FSY.TO income_statement (quarterly, 2025-12-31) — Interest Income: 55725.00
FSY.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 117048.00
FSY.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 55725.00
FSY.TO cash_flow (annual, 2025-12-31) — Interest Received Cfi: 117048.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 55725.00
FSY.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 43519938.00
FSY.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4805537.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1161494.00
FSY.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 23930760.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 18925760.00
FSY.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 23930760.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 18925760.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -385717.00
FSY.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1986545.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -385717.00
FSY.TO income_statement (annual, 2025-12-31) — Net Interest Income: 117048.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 55725.00
FSY.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 117048.00
FSY.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 55725.00
FSY.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1643088.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1562182.00
FSY.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -582207.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 3123159.00
FSY.TO balance_sheet (annual, 2025-12-31) — Net PPE: 26005105.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 26005105.00
FSY.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4340378.00
FSY.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 43519938.00
FSY.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1283877.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1283877.00
FSY.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -2122993.00
FSY.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -493913.00
FSY.TO income_statement (annual, 2025-12-31) — Normalized Income: -1983948.00
FSY.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -372639.00
FSY.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -2260041.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -301549.00
FSY.TO income_statement (annual, 2025-12-31) — Operating Income: -2125590.00
FSY.TO income_statement (quarterly, 2025-12-31) — Operating Income: -506991.00
FSY.TO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
FSY.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
FSY.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 244725467.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 244725467.00
FSY.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 276654.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 276654.00
FSY.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -18422492.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -18422492.00
FSY.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 3756000.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 3756000.00
FSY.TO income_statement (annual, 2025-12-31) — Other Gand A: 1163962.00
FSY.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 278593.00
FSY.TO income_statement (annual, 2025-12-31) — Other Income Expense: 21997.00
FSY.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 65549.00
FSY.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -117048.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -55725.00
FSY.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 24594.00
FSY.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 78627.00
FSY.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 332790.00
FSY.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 72128.00
FSY.TO balance_sheet (annual, 2025-12-31) — Payables: 278955.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Payables: 278955.00
FSY.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 278955.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 278955.00
FSY.TO income_statement (annual, 2025-12-31) — Pretax Income: -1986545.00
FSY.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -385717.00
FSY.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
FSY.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4340378.00
FSY.TO balance_sheet (annual, 2025-12-31) — Receivables: 179827.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 179827.00
FSY.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -186736364.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -186736364.00
FSY.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 628838.00
FSY.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 156270.00
FSY.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 1792800.00
FSY.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 434863.00
FSY.TO balance_sheet (annual, 2025-12-31) — Share Issued: 244725467.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 244725467.00
FSY.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
FSY.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
FSY.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 43519938.00
FSY.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 43519938.00
FSY.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FSY.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FSY.TO income_statement (annual, 2025-12-31) — Tax Provision: 0.00
FSY.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
FSY.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Assets: 45168297.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 45168297.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 43519938.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 43519938.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 43519938.00
FSY.TO income_statement (annual, 2025-12-31) — Total Expenses: 2125590.00
FSY.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 506991.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1648359.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1648359.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 26005105.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 26005105.00
FSY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1283877.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1283877.00
FSY.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -2597.00
FSY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -13078.00
FSY.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2597.00
FSY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -13078.00
FSY.TO balance_sheet (annual, 2025-12-31) — Working Capital: 18798710.00
FSY.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 18798710.00
FSY.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 841484.00
FSY.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 238292.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 92277.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 49822289.00
FSY.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 244725467.00
FSY.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 18706711.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -20940.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 195100505.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 17537793.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 17537793.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 16494578.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1043215.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -437764.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -730155.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -40663.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 54375.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 87550.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 101262.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1167919.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 195100505.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 42536525.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 17852349.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 83879.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 322171.00
FSY.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 244725467.00
FSY.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
FSY.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — EBIT: -841484.00
FSY.TO income_statement (quarterly, 2026-03-31) — EBITDA: -841484.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -999.00
FSY.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 17537793.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -751095.00
FSY.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4241.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -18656412.00
FSY.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 616419.00
FSY.TO income_statement (quarterly, 2026-03-31) — Interest Income: 81924.00
FSY.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 81924.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 81924.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 42536525.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -437764.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -749493.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -749493.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 81924.00
FSY.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 81924.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -498748.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 26258270.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -20940.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 42536525.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1251923.00
FSY.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -845725.00
FSY.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -753734.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -730155.00
FSY.TO income_statement (quarterly, 2026-03-31) — Operating Income: -841484.00
FSY.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 244725467.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 222279.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -18656412.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 3756000.00
FSY.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 409084.00
FSY.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 10067.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -81924.00
FSY.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 5826.00
FSY.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 225065.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Payables: 238292.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 238292.00
FSY.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -749493.00
FSY.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -20940.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 92277.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -187485857.00
FSY.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 207335.00
FSY.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 616419.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 244725467.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 42536525.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 42536525.00
FSY.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
FSY.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 44110619.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 42536525.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 42536525.00
FSY.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 841484.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1574094.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 26258270.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1251923.00
FSY.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 4241.00
FSY.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 4241.00
FSY.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 17530178.00
FSZ.TO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
FSZ.TO balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
FSZ.TO income_statement (annual, 2021-12-31) — Basic Average Shares: 103839056.00
FSZ.TO income_statement (annual, 2021-12-31) — Basic EPS: 0.71
FSZ.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
FSZ.TO income_statement (annual, 2021-12-31) — Diluted Average Shares: 116541545.00
FSZ.TO income_statement (annual, 2021-12-31) — Diluted EPS: 0.68
FSZ.TO balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 4723000.00
FSZ.TO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -15927000.00
FSZ.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 15927000.00
FSZ.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
FSZ.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
FSZ.TO balance_sheet (annual, 2021-12-31) — Other Equity Interest: 3339000.00
FSZ.TO balance_sheet (annual, 2021-12-31) — Other Properties: 77763000.00
FSZ.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 16428000.00
FSZ.TO cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 2959000.00
FSZ.TO cash_flow (annual, 2021-12-31) — Sale Of Business: 54823000.00
FSZ.TO income_statement (annual, 2022-12-31) — +Operating Expense: 328256000.00
FSZ.TO income_statement (annual, 2022-12-31) — +Total Revenue: 664892000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 65604000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 137397000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -95226000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 19500000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 38447000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 38447000.00
FSZ.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 102447711.00
FSZ.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.25
FSZ.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 102594000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 130703000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -4921000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 94688000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 813880000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 62199000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 68213000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -87984000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -148150000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -6340000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 113310000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: -81771000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -15575000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2283000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Payable: -86494000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -86494000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -5361000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 62400000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -42747000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 62400000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -41180000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Common Stock: 813880000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -87984000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 341045000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -33998000.00
FSZ.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 239606000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Assets: 250277000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 15989000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 15989000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 11167000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 11167000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 225893000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 15994000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 10123000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Deferred Tax: 10123000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Depreciation: 19175000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 57622000.00
FSZ.TO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 57622000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 57622000.00
FSZ.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 57622000.00
FSZ.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 104190313.00
FSZ.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.24
FSZ.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 25353000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 22597000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 0.00
FSZ.TO income_statement (annual, 2022-12-31) — EBIT: 81864000.00
FSZ.TO income_statement (annual, 2022-12-31) — EBITDA: 139486000.00
FSZ.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 16547000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -16547000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 785000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 800000.00
FSZ.TO cash_flow (annual, 2022-12-31) — End Cash Position: 62199000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6574000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -148150000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 108389000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 15793000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
FSZ.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
FSZ.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2288000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -16675000.00
FSZ.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 260807000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Goodwill: 650981000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 911036000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 186102000.00
FSZ.TO income_statement (annual, 2022-12-31) — Gross Profit: 425286000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 2510000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 9608000.00
FSZ.TO income_statement (annual, 2022-12-31) — Insurance And Claims: 4987000.00
FSZ.TO income_statement (annual, 2022-12-31) — Interest Expense: 40219000.00
FSZ.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 40219000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Interest Paid Cff: -33630000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 992654000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -6340000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 6574000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 21180000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 884000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 13722000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 112697000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Leases: 30869000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 78699000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 651609000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 730308000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 112697000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -103780000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 14606000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 24530000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 5836000.00
FSZ.TO income_statement (annual, 2022-12-31) — Minority Interests: -6169000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -5795000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -33998000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Net Debt: 589410000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income: 25353000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 25353000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 31522000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 25353000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 25353000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 31522000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 31522000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -4921000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Interest Income: -41164000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 1393000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 8917000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 8917000.00
FSZ.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -41164000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1831000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -19614000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Net PPE: 90876000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -569991000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 32164000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 9321000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 32164000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 9321000.00
FSZ.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 155908000.00
FSZ.TO income_statement (annual, 2022-12-31) — Normalized Income: 37783166.50
FSZ.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 113310000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -754000.00
FSZ.TO income_statement (annual, 2022-12-31) — Operating Income: 97030000.00
FSZ.TO income_statement (annual, 2022-12-31) — Operating Revenue: 658830000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 102640479.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 16347000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15084000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -16675000.00
FSZ.TO income_statement (annual, 2022-12-31) — Other Gand A: 203091000.00
FSZ.TO income_statement (annual, 2022-12-31) — Other Income Expense: -14221000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 260055000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 36905000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 23798000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 16128000.00
FSZ.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -14346000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Payable: 75580000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Properties: 67150000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 9350000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 6014000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Payables: 152425000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 152425000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 15234000.00
FSZ.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 32913000.00
FSZ.TO income_statement (annual, 2022-12-31) — Pretax Income: 41645000.00
FSZ.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 376000.00